Newsletters
DTN 019: The AI Boom has a Chip Problem
Plus: Most aliens may be AI, a crypto-longevity research state called Zuzalu, crypto investment is down bad, and more.
Newsletters
DTN 018: Transforming Hydrogen Fuel Cells
Plus: A wooden satellite, sending a physical Bitcoin to the moon, a paralyzed man walks again, toward a 100,000 qubit quantum computer, and more.
Conversations
Transforming Hydrogen Fuel Cells with EH Group’s Christopher Brandon
Christopher Brandon is the cofounder and director of EH Group Engineering, a startup building next generation hydrogen fuel cells.
Newsletters
DTN 017: Decentralizing Longevity Research Funding
Plus: A new human genome project, Microsoft buys fusion energy, a battery you can eat, Texas wants to create a gold-backed digital currency, and more.
Conversations
Decentralizing Longevity Research Funding with VitaDAO’s Laurence Ion
Laurence Ion is a steward at VitaDAO, a community-owned collective funding early-stage longevity research and drug development. He is a longevity advocate, entrepreneur, investor, and a Dealflow Steward in VitaDAO.
Newsletters
DTN 016: An Alzheimer's Breakthrough
Plus: Brain surgery on a fetus, Dorsey's Bitcoin Legal Defense Fund goes to court, scientists rail against Germany's nuclear phaseout disaster, and more.
Newsletters
DTN 015: Brain images just got 64 million times sharper
Plus: Telescopes on the moon, solar sails for interstellar travel, DIY brain-computer interfaces, and more.
Newsletters
DTN 014: Toward Hyperdimensional Computing
Plus: German students prepare for record-setting space shot, open sourcing nuclear physics, robot lawyers, a new Uranium isotope, and more.
Newsletters
DTN 013: The State of AI 2023
Plus: A guy makes ChatGPT the CEO of his company, China inserts tardigrade DNA into human stem cells, and more
Newsletters
DTN 012: The De-Extinction Business with Colossal CEO Ben Lamm
Plus: A leaky nuclear reactor, a chatbot suicide, a government crypto conspiracy, artificial cells, and more.
Conversations
The De-extinction Business with Colossal Biosciences’ Ben Lamm
Ben Lamm is the cofounder and CEO of the de-extinction company Colossal Biosciences.
Newsletters
DTN 011: OpenAI Says 80% of U.S. Jobs Will Be Impacted by GPT
Plus: A landmine hunting drone, Japan's geothermal opportunity, successful launch of the world's first 3D printed rocket, DeSantis and Cruz go after CBDCs, and more.